03:18 AM EDT, 10/07/2024 (MT Newswires) -- Michael Thomas Henderson, Director, Chief Executive Officer, on October 02, 2024, sold 40,000 shares in Apogee Therapeutics ( APGE ) for $2,249,307. Following the Form 4 filing with the SEC, Henderson has control over a total of 1,354,487 shares of the company, with 1,354,487 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1974640/000110465924106364/xslF345X05/tm2425574-2_4seq1.xml

Price: 54.40, Change: -0.08, Percent Change: -0.15